FDA allows marketing of IDx-DR artificial intelligence device for diabetic retinopathy detection

The FDA has permitted the marketing of IDx-DR, the first artificial intelligence medical device to detect more than a mild level of diabetic retinopathy in adults with diabetes, according to a press release. IDx-DR (IDx LLC), a software program that uses an artificial intelligence algorithm to analyze images ...